logo
The Dangers of Turning to AI for Mental Health Support

The Dangers of Turning to AI for Mental Health Support

Yahoo5 days ago
It's late at night. You should be sleeping, but the crushing weight of anxiety is keeping you awake. You open ChatGPT for a safe space to vent. It validates your feelings. And you feel surprisingly better.
If you recognize yourself in this scenario, you're not alone. 22% of Americans said that they have used a mental health chatbot, according to a survey conducted by Woebot Health — and 47% would be interested in using an AI therapist.
The top reason for using AI for mental health support? Receiving empathetic, non-judgemental support. 'Many people aren't comfortable being vulnerable with another human. Talking to AI feels safer,' says Citlali Herrera, founder and psychotherapist at Inner Worlds Psychotherapy. The cost of therapy is another factor, adds Herrera, as well as the fact that AI is available instantly.
RELATED: What Types of Therapy Are Best for Men?
But while AI can offer an immediate — and soothing — response, relying on it for emotional support is a slippery slope. From stunting your growth to exposing your data, here are some of the risks of treating AI like a therapist.
It Can Reinforce Isolation
Healing happens in connection and relationships, not in isolation. The more you confide in a chatbot, the more you risk isolating yourself. This habit can reinforce the belief that you have to handle everything on your own, which is particularly harmful for men, says Emma Giordano LMHC at Empower Your Mind Therapy:
'Men are frequently judged for expressing their emotions and being vulnerable with others. AI will never be able to give you the real-life experiences necessary to truly help you learn that there are people in the world who will understand you and support you unconditionally.'
It Can Become an Echo Chamber
AI can become an echo chamber, adds Herrera — one that validates your pain on demand but doesn't challenge your beliefs or help you unpack deeper patterns. Unless you prompt it, of course, but part of the point of therapy is shining light on your blind spots.
'AI can only help you based on what you share, and part of therapy is about helping you understand things about yourself and your life that you are not yet aware of,' adds Giordano.
Plus, as Veronica Shelton, AI expert, co-founder and head of creative and technology at Oak Theory, notes, if your emotional literacy is low to begin with, you might not even know what to ask.
It Can Delay Necessary Professional Help
Turning to AI for mental health support can even put your mental health at risk. According to Herrera, people often use AI to research a diagnosis, something to name their pain. Without a trained clinician, this can easily lead to misdiagnosis and delay real help.
Therapists are trained to assess risk and safety. They can 'catch the nuances of trauma, suicidality and abuse,' says Giordano. A delay in obtaining professional help could have devastating consequences in some cases.
It Can't Observe Non-Verbal Cues
Your body language, facial expressions and tone reveal a lot. A skilled therapist picks up on them and uses those insights to support you better. 'These forms of human behavior are essential in therapeutic treatment when a person is unwilling to share what they are thinking or is unaware of what is happening in their mind and body,' adds Giordano. As Shelton puts it, AI 'can walk with you through your thoughts, but it can't sit in your silence.'
It Can Encourage Emotional Bypassing
Shelton, who uses AI to reflect and self-regulate, also wants men to know that it's easy to fall into the trap of intellectualizing your emotions instead of actually processing them: 'You become a master of talking about your feelings without ever feeling them.'
It seems productive, but you're not actually working through your feelings, which means they stay lodged in your body, unresolved. Over time, that emotional avoidance can lead to other problems, from chronic stress and sleep issues to feeling disconnected from yourself and others.
It Can Stunt Your Growth
Using AI for emotional support can stunt your growth. According to Giordano, it can hurt your ability to communicate and interact with others, which has a negative impact on your relationships. 'Humans do not respond like AI. AI 'companions' will never initiate a conflict, and will apologize and change course the moment you express your discontent,' says Giordano.
The kicker? Resolving conflict is a necessary life skill. When you learn to do it productively, it can strengthen your relationships. On the other hand, when you become accustomed to talking to a chatbot that never disagrees with you, you lack the tools to cope with interpersonal challenges.
It Can Make Your Data Vulnerable
It's easy to feel like you're in a private bubble when it's just you and the screen, but that sense of confidentiality is an illusion. Do you really want ChatGPT to know your deepest, darkest secrets? Ultimately, everything you share is data — and the moment you hit that enter button, you lose control over where it goes or how it's used.
AI can be a helpful tool for self-reflection. But it's important to treat it as such. It might feel like a safe space, but using it as a replacement for therapy comes with dangers, including keeping you emotionally stuck.
You Might Also Dig:
How to Build Up Your Confidence
Does Weed Help Anxiety?
How to Motivate Yourself to Work Out When You're Depressed
Solve the daily Crossword
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Why Novo Nordisk Stock Bumped Higher on Friday
Why Novo Nordisk Stock Bumped Higher on Friday

Yahoo

time21 minutes ago

  • Yahoo

Why Novo Nordisk Stock Bumped Higher on Friday

Key Points The Federal government might boost its support of weight-loss drugs soon. According to a media report, it's contemplating a five-year, experimental program that would subsidize their costs for qualifying patients. 10 stocks we like better than Novo Nordisk › Unexpected news of a potential support program from the federal government boosted the share prices of weight-loss drug developers on Friday. The poster boy for that still rather small group, Wegovy/Ozempic maker Novo Nordisk (NYSE: NVO), understandably saw a stock price lift that day. It rose by more than 2%, contrasting well with the 1.6% slide of the S&P 500 index. Federal help for obesity drugs? That news came from The Washington Post, which published an article stating that the Trump administration is planning an experimental program that would cover the costs of such medications. Citing documents from the Centers for Medicare and Medicaid Services (CMS) it had obtained, the newspaper said the plan would be implemented by state Medicaid administrations. It would also be utilized by Medicare Part D insurance plans. These entities would be allowed to cover weight-loss drugs for qualifying patients. At the moment, Medicare generally covers such treatments for patients who suffer from type 2 diabetes. Both Novo Nordisk's Wegovy and rival Eli Lilly's Zepbound are essentially versions of predecessor diabetes drugs. Some private insurance plans cover obesity medications. The Post wrote that the experimental program will last for five years. Massive potential impact Novo Nordisk hasn't yet commented on the article, but we can be sure the company is excited about the prospect. Combined, Medicare and Medicaid are immense programs. Even if only a few states are willing to cover weight-loss treatments through them, the company could experience a surge in sales. For the stock's investors, this is a potentially very impactful development well worth monitoring. Should you buy stock in Novo Nordisk right now? Before you buy stock in Novo Nordisk, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Novo Nordisk wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $625,254!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,090,257!* Now, it's worth noting Stock Advisor's total average return is 1,036% — a market-crushing outperformance compared to 181% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. Why Novo Nordisk Stock Bumped Higher on Friday was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Addus HomeCare (ADUS) Q2 Earnings: What To Expect
Addus HomeCare (ADUS) Q2 Earnings: What To Expect

Yahoo

time22 minutes ago

  • Yahoo

Addus HomeCare (ADUS) Q2 Earnings: What To Expect

Home healthcare provider Addus HomeCare (NASDAQ:ADUS) will be reporting results this Monday afternoon. Here's what you need to know. Addus HomeCare missed analysts' revenue expectations by 0.6% last quarter, reporting revenues of $337.7 million, up 20.3% year on year. It was a mixed quarter for the company, with a narrow beat of analysts' sales volume estimates. Is Addus HomeCare a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Addus HomeCare's revenue to grow 20.8% year on year to $346.5 million, improving from the 10.4% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.46 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Addus HomeCare has missed Wall Street's revenue estimates three times over the last two years. Looking at Addus HomeCare's peers in the senior health, home health & hospice segment, some have already reported their Q2 results, giving us a hint as to what we can expect. BrightSpring Health Services delivered year-on-year revenue growth of 15.3%, beating analysts' expectations by 5.2%, and Option Care Health reported revenues up 15.4%, topping estimates by 4.6%. Option Care Health traded down 2.7% following the results. Read our full analysis of BrightSpring Health Services's results here and Option Care Health's results here. The euphoria surrounding Trump's November win lit a fire under major indices, but potential tariffs have caused the market to do a 180 in 2025. While some of the senior health, home health & hospice stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 4.3% on average over the last month. Addus HomeCare is down 5.3% during the same time and is heading into earnings with an average analyst price target of $136.45 (compared to the current share price of $104.74). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

USDOT pulls the plug on $26 million MagLev project citing poor planning, rising costs
USDOT pulls the plug on $26 million MagLev project citing poor planning, rising costs

CBS News

time36 minutes ago

  • CBS News

USDOT pulls the plug on $26 million MagLev project citing poor planning, rising costs

Sean P. Duffy, the U.S. Department of Transportation Secretary, cancelled two grants that would've funded the proposed high speed MagLev train between Baltimore to Washington, D.C. The USDOT along with the Federal Railroad Administration (FRA) made the announcement on Friday calling off two grants totaling over $26 million for the Super Magnetic Levitation Project (SCMAGLEV). The project was highly favored by Governor Moore, who traveled to Ogatayama, Japan in April during a trade mission to test ride the train. The press release cites the ending of the government's involvement due to, "a decade of poor planning, significant community oppositions, tremendous cost overruns, and nothing to show for it..." "We want big, beautiful projects worthy of taxpayer dollars – including high-speed rail. This project lacked everything needed to be a success from planning to execution. This project did not have the means to go the distance, and I can't in good conscience keep taxpayers on the hook for it," said U.S. Transportation Secretary Sean P. Duffy. "We'll continue to look for exciting opportunities to fund the future of transportation and encourage innovation." The FRA also claims the project would have major negative impacts to federal and national security agencies. Sincer 2016, when the FRA began working on the project, there have been many delays along with rising costs. The environmental review process for the project has also been stopped two times on the Federal Permitting Dashboard. It has been on hold since August 2021 until now. Overall, the estimated cost to complete the project would have been nearly $20 billion. The MagLev, short for magnetic levitation, is the world's fastest train. Some models are reportedly able to reach speeds of 370 miles per hour using magnetic fields to lift and propel trains without direct contact with train tracks. Without the friction caused when train wheels touch their tracks, the train can essentially levitate, creating a smoother, faster experience. The train had the potential to boost Maryland's economy, per Wayne Rogers, Northeast Maglev Chair. According to him, the project could have created over 160,000 jobs. However, many Marylanders whose homes were in the path of the proposed project were angry with the thought of a high speed train in their backyard.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store